Jupiter Neurosciences, Inc. (JUNS)
NASDAQ: JUNS · Real-Time Price · USD
0.1650
-0.0075 (-4.35%)
At close: Jul 20, 2026, 4:00 PM EDT
0.1745
+0.0095 (5.76%)
Pre-market: Jul 21, 2026, 5:52 AM EDT
Jupiter Neurosciences Employees
Jupiter Neurosciences had 5 employees as of December 31, 2025. The number of employees increased by 1 or 25.00% compared to the previous year.
Employees
5
Change (1Y)
1
Growth (1Y)
25.00%
Revenue / Employee
$8,090
Profits / Employee
-$1,835,598
Market Cap
7.16M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 5 | 1 | 25.00% |
| Dec 31, 2024 | 4 | 0 | - |
| Jun 30, 2024 | 4 | - | - |
| Mar 31, 2024 | 4 | - | - |
| Dec 31, 2023 | 4 | -1 | -20.00% |
| Sep 30, 2022 | 5 | 0 | - |
| Jun 30, 2022 | 5 | 0 | - |
| Mar 31, 2022 | 5 | 0 | - |
| Sep 30, 2021 | 5 | - | - |
| Jun 30, 2021 | 5 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Imunon | 20 |
| AEON Biopharma | 8 |
| CNS Pharmaceuticals | 8 |
| Ernexa Therapeutics | 7 |
| Can-Fite BioPharma | 5 |
| XTL Biopharmaceuticals | 5 |
| Kairos Pharma | 4 |
| Acurx Pharmaceuticals | 4 |
JUNS News
- 13 days ago - Jupiter Neurosciences Strengthens Board with Appointment of Dr. Tomas J. Philipson - GlobeNewsWire
- 24 days ago - Jupiter Neurosciences files to sell 16M shares of common stock for holders - TheFly
- 7 weeks ago - Jupiter Neurosciences commences patient enrollment in RESET trial - TheFly
- 7 weeks ago - Jupiter Neurosciences Announces Patient Enrollment Underway in Phase 2a RESET Trial in Parkinson's Disease - GlobeNewsWire
- 7 weeks ago - D. Boral Capital Acted as Exclusive Placement Agent to Jupiter Neurosciences, Inc. (Nasdaq:JUNS) in Connection with its ~$2 Million Registered Direct Offering - Accesswire
- 2 months ago - Jupiter Neurosciences Announces Closing of $2.0 Million Registered Direct Offering - GlobeNewsWire
- 2 months ago - Jupiter Neurosciences announces pricing of $2M registered direct offering - TheFly
- 2 months ago - Jupiter Neurosciences Announces Pricing of $2.0 Million Registered Direct Offering - GlobeNewsWire